Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Insmed Reports Third Quarter 2019 Financial Results and Provides Business Update

Insmed (INSM) Misses Q3 EPS by 1c, Revenues Beat

October 30, 2019 7:39 AM EDT

Insmed (NASDAQ: INSM) reported Q3 EPS of ($0.68), $0.01 worse than the analyst estimate of ($0.67). Revenue for the quarter came in at $38.9 million versus the consensus estimate of $35.89 million.

Third Quarter 2019 Financial Results

Total revenue for the third quarter ended September 30, 2019 was $38.9 million, comprising U.S. net sales of $37.8 million and ex-U.S. net sales of $1.1 million. The ex-U.S. net product sales include $0.9 million from the Temporary Authorization for Use (Autorisation Temporaire d\'Utilisation or ATU) program in France and $0.2 million from the named patient program in Germany, both compassionate use programs.Cost of... More